STUDY GROUP ON PRIMARY HEADACHES, FIBROMYALGIA AND PSYCHOACTIVE DRUGS
(Ref. CTS-502)
14
mayo
2025
mayo 2025
| L | M | X | J | V | S | D |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
Datos del grupo
Líneas de investigación
| Líneas: |
|---|
| None: |
| None: |
| None: |
| None: |
| None: |
| None: |
| None: |
| FIBROMYALGIA: 1.1 THERAPEUTIC EVALUATION OF PSYCHOACTIVE DRUGS 1.2 PSYCHOLOGICAL ASPECTS 1.3 GASTROINTESTINAL COMORBIDITY 1.4 DIETARY ASPECTS |
| None: |
| None: |
| None: |
| None: |
| None: |
| None: |
| None: |
| None: |
| None: |
| None: |
| None: |
| None: |
| None: |
| None: |
| None: |
| None: |
| None: |